Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

737 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Cohort Study to Evaluate Genetic Predictors for Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS): Results from ECOG-ACRIN E1Z11.
Stearns V, Jegede OA, Chang VT, Skaar TC, Berenberg JL, Nand R, Shafqat A, Jacobs NL, Luginbuhl W, Gilman P, Benson AB, Goodman JR, Buchschacher GL, Henry NL, Loprinzi CL, Flynn PJ, Mitchell EP, Fisch MJ, Sparano JA, Wagner LI. Stearns V, et al. Among authors: chang vt. Clin Cancer Res. 2024 Apr 19. doi: 10.1158/1078-0432.CCR-23-2137. Online ahead of print. Clin Cancer Res. 2024. PMID: 38640040
Urinary biomonitoring of glyphosate exposure among male farmers and nonfarmers in the Biomarkers of Exposure and Effect in Agriculture (BEEA) study.
Chang VC, Ospina M, Xie S, Andreotti G, Parks CG, Liu D, Madrigal JM, Ward MH, Rothman N, Silverman DT, Sandler DP, Friesen MC, Beane Freeman LE, Calafat AM, Hofmann JN. Chang VC, et al. Environ Int. 2024 May;187:108644. doi: 10.1016/j.envint.2024.108644. Epub 2024 Apr 11. Environ Int. 2024. PMID: 38636272 Free article.
Chilaiditi's Syndrome Mimicking Crohn's.
Aodish S, Chang V, Callow A. Aodish S, et al. Among authors: chang v. Cureus. 2024 Feb 21;16(2):e54655. doi: 10.7759/cureus.54655. eCollection 2024 Feb. Cureus. 2024. PMID: 38524032 Free PMC article.
Pharmacokinetic-Pharmacodynamic Evidence from a Phase 3 Trial to Support Flat-Dosing of Rifampicin for Tuberculosis.
Ngo HX, Xu AY, Velásquez GE, Zhang N, Chang VK, Kurbatova EV, Whitworth WC, Sizemore E, Bryant K, Carr W, Weiner M, Dooley KE, Engle M, Dorman SE, Nahid P, Swindells S, Chaisson RE, Nsubuga P, Lourens M, Dawson R, Savic RM. Ngo HX, et al. Among authors: chang vk. Clin Infect Dis. 2024 Mar 11:ciae119. doi: 10.1093/cid/ciae119. Online ahead of print. Clin Infect Dis. 2024. PMID: 38462673
737 results